Skip to main content

Table 1 Summary of socio-demographic and clinical characteristics of study participants

From: Defining the relationship between clinician-rated ECOG performance status and patient-reported health-related quality of life scores in men with metastatic hormone-naïve prostate cancer

Parameter

Value

Mean age (yrs)

70.62 ± 7.34

Mean BMI (kg/m2)

24.10 ± 3.43

Mean tPSA (ng/ml)

91.65 ± 66.43

Median tPSA (ng/ml)

83.70(IQR 47.90–107.00)

Formal Education Attainment

 

 Less than Secondary Level: n(%)

88 (39.3%)

 Secondary Level and Higher: n(%)

136 (60.7%)

Symptoms at Study Entry

 

 LUTS: n(%)

216 (96.4%)

 Bone Pain: n(%)

204 (91.1%)

 Weight Loss: n(%)

169 (75.4%)

 Acute/Chronic Urinary Retention: n(%)

101 (45.1%)

 Paraparesis/Paraplegia: n(%)

47 (23.0%)

 Haematuria: n(%)

35 (15.6%)

 Need for Blood Transfusion: n(%)

18 (8.0%)

ISUP Grade

 

 Grade 1: n(%)

24 (10.7%)

 Grade 2: n(%)

10 (4.5%)

 Grade 3: n(%)

34 (15.2%)

 Grade 4: n(%)

55 (24.6%)

 Grade 5: n(%)

101 (45.1%)

ECOG-PS Score

 

 ECOG 1: n(%)

51 (22.8%)

 ECOG 2: n(%)

125 (55.8%)

 ECOG 3: n(%)

47 (21.0%

 ECOG 4: n(%)

1 (0.4%)

Mean FACT-P Score

80.18 ± 17.56

Mean HUI

0.524 ± 0.324

Mean VAS

60.43 ± 9.91

  1. [BMI: body mass index; tPSA: total serum prostate-specific antigen; LUTS: lower urinary tract symptoms; ISUP: international society of urological pathology; ECOG-PS: eastern cooperative oncology group – performance status; FACT-P: functional assessment for cancer therapy – prostate; HUI: health utility index; VAS; visual analogue scale]